AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Michael Schaapveld

Michael Schaapveld

Netherlands Cancer Institute - Amsterdam / Netherlands
Others
AD Scientific Index ID: 4963231
Nederlands Kanker Instituut
person_outline Michael Schaapveld's MOST POPULAR ARTICLES
1-) Second cancer risk up to 40 years after treatment for Hodgkin’s lymphoma New England Journal of Medicine 373 (26), 2499-2511, 2015
2-) Morbidity and mortality of inadvertent enterotomy during adhesiotomy Journal of British Surgery 87 (4), 467-471, 2000
3-) Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk JAMA internal medicine 175 (6), 1007-1017, 2015
4-) Long-term risk of second malignancy in survivors of Hodgkin’s disease treated during adolescence or young adulthood Journal of Clinical Oncology 18 (3), 487-487, 2000
5-) Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma Journal of clinical oncology 34 (3), 235-243, 2016